United States
TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform
This technology from scientists at Los Alamos National Laboratory represents a novel platform for improving the safety and effectiveness of therapeutic gas-based treatments by enabling controlled, localized delivery at the site of disease. By addressing longstanding challenges associated with systemic exposure and…
- Buyer
- ENERGY, DEPARTMENT OF - TRIAD - DOE CONTRACTOR
- Country
- United States
- Location
- Los Alamos, NM, USA
- Deadline
- December 4, 2026
- Published
- June 4, 2026
- Procedure
- Special Notice
- Source
- SAM.gov
See the full tender, the documents and similar tenders
Scoutee reads more than 100 public procurement portals across Europe and North America and brings their tenders together in one search. The free account shows the buyer's notice and its documents.
Other tenders from this buyer
- TIDAL: Target-Induced Droplet Assembly of LigandsDeadline December 9, 2026
- TECHNOLOGY LICENSING OPPORTUNITY: AmineBind MLDeadline March 2, 2027
- TECHNOLOGY LICENSING OPPORTUNITY: Advanced Metal Hydride Microreactor PlatformDeadline September 14, 2026
CPV NAICS:325412, PSC:6505